Text Size
10 studies found for:    Alzheimer's | Open Studies | United States, Utah

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Alzheimer's | Open Studies | United States, Utah
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
2 Recruiting Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo
3 Recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo
4 Recruiting Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027;   Drug: Placebo matching BMS-241027
5 Recruiting Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
6 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738 AM3)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
7 Recruiting A Study of Gantenerumab in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: gantenerumab;   Drug: placebo
8 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
9 Recruiting Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir (18F)
10 Recruiting Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
To Top

† Indicates status has not been verified in more than two years